Close

Exelixis (EXEL) Announces U.S. FDA Accepts IND Application for XB002 in Patients with Advanced Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Exelixis (EXEL) Announces U.S. FDA Accepts IND Application for XB002 in Patients with Advanced Solid Tumors
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 23.53 --0 (-0%)
Previous Close $23.53    52 Week High $17.00 
Open $23.53    52 Week Low $3.55 
Day High $23.53    P/E N/A 
Day Low $23.53    EPS $-1.33 
Volume 102